A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12884-016-0934-8

PubMed Identifier: 27411564

Publication URI: http://europepmc.org/abstract/MED/27411564

Type: Journal Article/Review

Volume: 16

Parent Publication: BMC pregnancy and childbirth

Issue: 1

ISSN: 1471-2393